US64110W1027 - ADR
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 87.606B 18.92% | 96.496B 10.15% | 103.468B 7.23% | 116.875B 12.96% | ||||||||
EBITDA YoY % growth | 19.693B 9.42% | 22.487B 14.19% | 30.764B 36.81% | 37.059B 20.46% | ||||||||
EBIT YoY % growth | 16.417B 12.92% | 19.629B 19.57% | 27.709B 41.16% | 34.103B 23.07% | ||||||||
Operating Margin | 18.74% | 20.34% | 26.78% | 29.18% | ||||||||
EPS YoY % growth | 29.26 32.41% | 34.60 18.25% | 50.15 44.94% | 53.27 6.21% | N/A | N/A | N/A | N/A | N/A |
All data in CNY
Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 12.91 11.07% | |||||||||||
Revenue Q2Q % growth | 27.387B 9.35% | |||||||||||
EBITDA Q2Q % growth | 9.112B | |||||||||||
EBIT Q2Q % growth | 8.344B 15.57% |
All data in CNY
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 11.35 54.42% | 12.58 | -1.23 | -9.75% |
Q3 2023 Q2Q % growth | 13.30 17.18% | 10.85 | 2.45 | 22.59% |
Q2 2023 Q2Q % growth | 13.88 69.27% | 9.25 | 4.63 | 50.13% |
Q1 2023 Q2Q % growth | 11.62 50.91% | 8.99 | 2.63 | 29.30% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 27.14B 7.04% | 28.89B | -1.75B | -6.06% |
Q3 2023 Q2Q % growth | 27.27B 11.64% | 28.281B | -1.011B | -3.57% |
Q2 2023 Q2Q % growth | 24.011B 3.68% | 25.452B | -1.441B | -5.66% |
Q1 2023 Q2Q % growth | 25.046B 6.33% | 25.534B | -488M | -1.91% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | -0.1% | -1.3% | 0.95% | 0.83% |
Revenue | 0.23% | -4.4% | -0.56% | -1.72% |